Vellumet - Lipid Soluble Heavy Metal Detox

Lipid Soluble Heavy Metal Detox Vellumet by RemedyLink is formulated with a lipid-soluble macrocyclic chelating matrix to support deep cellular heavy metal binding, system detoxification, and cellular defense. Supports the body in dealing with brain and intercellular toxic metals such as aluminum, lead, gadolinium, cadmium, uranium, iron, manganese, barium, silver, nickel, copper and thallium. Promotes Deep Cellular Heavy Metal Binding: The lipid-soluble structure allows the macrocyclic chelating agent to cross lipid-rich cell membranes, supporting the natural sequestration of systemic heavy metal ions. Supports Systemic Heavy Metal Clearance: Binds tightly to heavy transition metals and lanthanides, forming stable, non-reactive complexes that encourage safe, natural elimination through normal excretion pathways. Provides Potent Targeted Antioxidant and Cellular Defense: By bound-sequestration of free redox-active metal ions, it helps reduce metal-induced hydroxyl radical generation and supports cellular lipid membrane integrity. Encourages Normal Systemic Detoxification Pathways: Assists the body's natural liver and kidney drainage functions by locking up unwanted metallic debris for efficient bodily removal. Supports Neurological and Lipid-Rich Tissue Integrity: Enhanced lipophilicity facilitates targeted access to lipid-dense biological structures, helping protect delicate neural and systemic lipid membranes from oxidative stress. Details Key Properties and How DOTA Works Macrocyclic Structure: DOTA forms a rigid, 12-membered ring containing nitrogen and oxygen binding sites. Because of its cage-like arrangement, once a metal ion enters the DOTA ring, it binds so tightly that it rarely breaks free. High Thermodynamic Stability: It exhibits exceptionally high affinity for heavy metals, transition metals, and rare-earth elements (lanthanides), preventing those metals from reacting freely or causing toxic reactions in biological tissue. Primary Applications Heavy Metal Sequestration Because of its macrocyclic binding strength, specialized or modified lipid-soluble forms of DOTA-like derivatives are researched for deep cellular heavy metal binding, helping to sequester metal ions out of biological tissues. Targeted Cancer Therapeutics (Radiopharmaceuticals) In nuclear medicine, DOTA is attached to a targeting molecule (like a peptide or monoclonal antibody) and chelated with a radioactive metal ion (such as Yttrium-90, Lutetium-177, or Actinium-225). The molecule guides the radioactive package directly to tumor cells (e.g., DOTATATE therapy for neuroendocrine tumors). Medical Imaging (Contrast Agents) DOTA complexed with Gadolinium ($Gd^{3+}$) forms gadoteric acid, a widely used magnetic resonance imaging (MRI) contrast agent. The DOTA ring securely traps the toxic gadolinium ion so it can safely highlight tissues on an MRI without harming the body. Ingredients Contains: Lipid soluble version of DOTA (dodecane tetraacetic acid). Instructions Directions for Use Start with Recommended Use Promotes deep cellular heavy metal binding, supports systemic heavy metal clearance, provides potent targeted antioxidant and cellular defense, encourages normal systemic detoxification pathways, and supports neurological and lipid-rich tissue integrity. Scientific References Harnessing and Enhancing Heavy Metal Detoxification Combating lead and cadmium exposure